Correction to: Oncogene
https://doi.org/10.1038/s41388-018-0557-9 Published online 2 November 2018
Since the publication of this paper, the authors noticed that the original version of this article contains errors in Figs. 2b and 3b.
In Fig. 2b, the authors noted that the treatment in SW620 cells was listed mistakenly as CAF2-exo. The correct information is 18Co-exo.
In Fig. 3b, the colours of the labels representing the low risk and high risk groups did not match and the numbers of the patients were incorrect.
The corrected figures are provided below.
The conclusions of this paper were not affected. The authors sincerely apologize for these errors and any confusion caused.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hu, YB., Yan, C., Mu, L. et al. Correction: Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance. Oncogene 38, 6319–6321 (2019). https://doi.org/10.1038/s41388-019-0863-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41388-019-0863-x
This article is cited by
-
DNAJB8 in small extracellular vesicles promotes Oxaliplatin resistance through TP53/MDR1 pathway in colon cancer
Cell Death & Disease (2022)